Immunotherapeutic Methods Using Epitopes of WT-1 and GATA-1

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13966454

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A peptide comprising the amino acid sequence RMFPNAPYL or a portion or variant thereof provided that the peptide is not intact human WT-1 polypeptide or a peptide comprising the amino acid sequence CMTWNQMNL or a portion or variant thereof provided that the peptide is not intact human WT-1 polypeptide or a peptide comprising the amino acid sequence HLMPFPGPLL or a portion or variant thereof provided that the peptide is not intact human gata-1 polypeptide, and polynucleotides encoding these peptides. The peptides and polynucleotides are useful as cancer vaccines.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GANYMED PHARMACEUTICALS AG55131 MAINZ

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
GAO, Liquan Ilford, GB 7 53
STAUSS, Hans Josef London, GB 7 79

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation